IMIDomics

Curated by Signal

Developer of medicines for the treatment of immune-mediated inflammatory diseases

Overview

Developer of medicines for the treatment of immune-mediated inflammatory diseases. The company combines exclusive access to data with biological insights to lead to precision discovery and targeting medicines for immune-mediated inflammatory diseases.

Key facts

Founded: 2015
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Mimic Technologies
Develops simulation training equipment for the Da Vinci surgical robotic systems
Life Sciences TechnologySeattle, United States
QT Medical
Developer of ECG devices and cardiac health monitoring tools
Life Sciences TechnologyTorrance, United States
RAW Molecular Systems
Developer of smart solutions for treating fungal pathogens
Life Sciences TechnologySpokane, United States

About IMIDomics

What does IMIDomics do?

Developer of medicines for the treatment of immune-mediated inflammatory diseases.

Where is IMIDomics headquartered?

IMIDomics is headquartered in San Francisco, United States.

When was IMIDomics founded?

IMIDomics was founded in 2015.

Which sector is IMIDomics in?

IMIDomics operates in Life Sciences Technology.

Who are IMIDomics's competitors?

Companies similar to IMIDomics include Mimic Technologies, QT Medical, and RAW Molecular Systems.